Hoshi Corporation Successfully Develops 3 Types of Made-in-Japan Health Food Supplements with Satisfactory Clinical Evidence

Food and Healthcare Press Releases Tuesday August 1, 2017 13:00
TOKYO--1 Aug--Kyodo JBN-AsiaNet/InfoQuest
  • Accepting Orders from July 24, 2017, amid Increasing Awareness of Health Promotion -

Hoshi Corporation, a cosmetic, quasi-drug and health food supplement manufacturer headquartered in Japan, has developed three types of health food supplements that are safe and secure. Based on our production philosophy of safe and high-quality product creation, we have developed over 20,000 products distributed all over the world.

Against the background of increasing awareness for health, beauty and longevity, we began accepting orders of safe and secure food supplements from July 24, 2017. Our made-in-Japan high-quality food supplements are available for import or for sale as your original products.

(Photo: http://prw.kyodonews.jp/img/201707284188-O1-UKtK77J8 )
Website: http://hoshicorp.jp/business/cosmeticsupplement/
Devices available for access: PCs, mobile phones
Product Information
1. Pueraria Mirifica Extract-containing Food Supplement (with Collagen)
We have completed clinical tests on this "Pueraria Mirifica"-containing supplement and obtained trial results of easing symptoms for women in menopausal disorder.
RESEARCH PAPER
(1) Efficacy on Breast Skin Tension of the Supplement Containing Pueraria Mirifica in Healthy Japanese Females: A Randomized, Double-blind, Placebo-controlled Study
  • Masatomo NAJIMA (JACTA (Japan Clinical Trial Association))
  • Akinobu MIYATA (Nihonbashi M's Clinic)
  • Hiroyuki SASAGAWA (Hoshi Corporation)
(2) Efficacy on Menopausal Discomfort of the Supplement Containing Pueraria Mirifica in Healthy Japanese Females: A Randomized, Double-blind, Placebo-controlled Study
  • Masatomo NAJIMA (JACTA (Japan Clinical Trial Association))
  • Mitsuhiko MUNEKATA (OZ Clinic)
  • Hiroyuki SASAGAWA (Hoshi Corporation)
2. RELAX & SLEEP - The good quality of sleep -

This health food supplement is a combination of "Theanine" which is widely known as functional food (*) and "PC-DHA" that is a kind of unsaturated fat of DHA (docosahexaenoic acid). It is actually reported that one in every five Japanese has some sleep disorders and troubles. (Reference from Annual Health, Labor and Welfare Report 2015)

Against the background of sleep disorder known as a modern disease, we have developed a food supplement to ensure sound sleep.
(*) Functional food is strictly examined as to its effects on health and registered with the Consumer Agency of Japan. It is a Japanese original system based on scientific grounds.
3. Placenta Drink, Placenta Jelly

It can be said that international scrutiny towards animal-derived ingredients becomes increasingly severe. MP (Marine Placenta) is extracted and purified from ovary membranes of domestic natural Hokkaido salmon. We have developed MP-containing jelly and drink. Fish-derived ingredients can give natural images to consumers. They feature our original formulation with 100% Japanese ingredients, non-caffeine and low calorie.

About Hoshi Corporation
Headquarters: 31-2, Kanda Higashi Matsushita-Cho, Chiyoda-Ku, Tokyo, 101-0042, JAPAN
Founded:   April 30, 1975
Capital:   80,000,000 yen
CEO:       Tsuneo Hoshino
President: Katsuo Kawashima
Major business areas:
  • Sales of cosmetic, pharmaceutical and health foods
  • Planning and sales of containers and packaging materials
  • Planning and contract manufacturing of cosmetic, pharmaceutical and health foods
SOURCE: Hoshi Corporation
AsiaNet 69505

Latest Press Release

Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease

-- Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol -- Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceutical company, today announced...

Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey

- Global Commission's recommendations focus on three solution pathways that leverage technology to address key elements of the rare disease diagnostic odyssey - Rare diseases remain undiagnosed as patients struggle to navigate complex health systems to...

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)...

Related Topics